|[January 09, 2013]
Research and Markets: Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/6b2nzg/innovation_in_the)
has announced the addition of the "Innovation
in the Prefilled Syringe Market - Biologics and Autoinjection Devices
Shaping Future R&D Trends" report to their offering.
Syringe Innovation Required to Take Advantage of Biologics Boom
The rise of biologic therapies will power growth in the prefilled
syringes market - but only if manufacturers can solve current product
problems, says a new report from healthcare industry experts GBI
As explained in the business intelligence firm's latest release*, the
development of injectable biologic therapies is a major factor for the
future prospects of prefilled syringes, as many peptides contained in
oral formulations are broken down too quickly in the stomach,
compromising their effectiveness.
Currently, many biologic therapies are incompatible with the silicone
used in glass syringes, necessitating a move to plastic variations and
the development of new polymers and coatings that minimize reactions
between the syringe material and the drug that cause contamination.
Glass has been the primary material in syringe manufacturing for
decades, but is slowly being replaced as the advantages of polymer-based
alternatives become apparent. Other than the possibility of product
contamination, glass syringes are more fragile and are prone to flaking,
but existing plastic versions are not without their own faults.
Cyclo-olefin polymers and co-polymers are the most commonly used plastic
syringe variants in the market today, with several companies offering
prefilled syringes in this form. However, while they are more durable
and less likely to feature manufacturing defects than their glass
counterparts, they are also more expensive to produce and are
economically unsuitable for low price drugs.
Polypropylene syringes have been around since the 1990s, and although
cheaper than the aforementioned plastics, it is a less transparent
material and more difficult to sterilize.
GBI Research's new report also predicts that the prefilled syringe
market will be driven by the growth of home use and auto-injection
devices that use a button-push mechanism - an innovative response to the
common fear of needles.
This report includes an overview of problems and possible solutions, as
well as discussion of how the devices have developed to date to address
problems with contamination, safety, fragility and ease of use.
This report was built using data and information sourced from
proprietary databases, primary and secondary research, and in-house
analysis conducted by GBI Research's team of industry experts.
For more information visit http://www.researchandmarkets.com/research/6b2nzg/innovation_in_the
[ Back To Technology News's Homepage ]